NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.410
-0.060 (-1.73%)
Sep 9, 2026, 12:33 PM EDT - Market open
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $147.53 million as of September 9, 2026. Its market cap has increased by 163.44% in one year.
Market Cap
147.53M
Enterprise Value
121.67M
1-Year Change
163.44%
Ranking
Category
Stock Price
$3.41
ChartMarket Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has increased from $65.80M to $147.53M, an increase of 124.20%. That is a compound annual growth rate of 9.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 147.53M | 93.86% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 161.96M |
| Milestone Pharmaceuticals | 158.52M |
| Jyong Biotech | 157.37M |
| Codexis | 156.59M |
| Outlook Therapeutics | 155.93M |
| Equillium | 152.81M |
| Tenaya Therapeutics | 148.75M |
| Inovio Pharmaceuticals | 146.82M |